| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Radiation Oncology Journal Search > Browse Articles > Search



Clinical Investigations
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy<img src='/image/flag/us.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Colin S. Hill<img src='/image/flag/us.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Shuchi Sehgal<img src='/image/flag/us.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Lei Zheng<img src='/image/flag/us.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Jin He<img src='/image/flag/us.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Daniel A. Laheru<img src='/image/flag/us.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Ana De Jesus-Acosta<img src='/image/flag/us.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Joseph M. Herman<img src='/image/flag/us.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Jeffrey Meyer<img src='/image/flag/us.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Amol K. Narang<img src='/image/flag/us.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>
Radiat Oncol J. 2022;40(2):111-119.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.01060
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 12  Crossref 12
The emerging role of myeloid-derived suppressor cells in radiotherapy
Changhee Kang<img src='/image/flag/kr.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Seong-Yun Jeong<img src='/image/flag/kr.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Si Yeol Song<img src='/image/flag/kr.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>, Eun Kyung Choi<img src='/image/flag/kr.gif' style='width:21px;height:13px;margin-top:4px;margin-left:5px;vertical-align:text-top;' class='img_a'>
Radiat Oncol J. 2020;38(1):1-10.   Published online 2020 Mar 25     DOI: https://doi.org/10.3857/roj.2019.00640
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 38  Crossref 40
1 |
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 1.8
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next